Moving Endocrinology Research Forward

It is estimated that 347 million people worldwide have diabetes and diabetes deaths will increase by two thirds globally between 2008 and 2030. The endocrine system is a complex group of glands that make hormones that moderate activities in your body – from reproduction to metabolism, to growth and development – and keep your body primed for action. Endocrinology challenges affect many conditions, many diseases, and many patients. Treatment is often complex and time consuming, and there is a growing need for medical research in this arena. 

SynteractHCR is working to move forward the current knowledge of endocrinology treatment, by supporting important clinical trials in this therapeutic area of research. SynteractHCR has successfully performed numerous Phase I-IV endocrinology studies in children and adolescents, as well as adults, ranging from:

  • Pharmacodynamic and pharmacokinetic studies
  • Safety and tolerability studies
  • Two-arm evaluation studies
  • Multiple dose studies
  • Titration studies
  • Pilot studies
  • Dose escalation studies
  • Drug/drug interaction studies
  • Active comparator-controlled studies
  • Observational studies

SynteractHCR Endocrinology Expertise

  • DPP4-inhibitors
  • Ghrelin-receptor Agonist
  • GLP-1-like drugs
  • Inhaled Insulin
  • Insulin Inhaler
  • Intravenously Administered Compounds
  • Monoclonal Antibody
  • Oral Insulin
  • Powder for Injection
  • Synthetic Peptides
  • Transdermal Insulin
  • Wound Care Devices

Well-rounded experience.

SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed 
to more than 230
product approvals
since our
Learn More

Contact SynteractHCR

  • USA: +1 760 268 8200
  • Europe: +49 89 12 66 80 0
  • Contact Form...

Contact SynteractHCR

Tell us how to stay in touch with you:

Required Fields(*)